Agency (Formerly Curology Adjacent) LegitScript and Accreditation Status: Is It Legit?

What Is Agency and How Does It Relate to Curology?

Agency is a direct-to-consumer prescription skincare platform that operates in the same telehealth model made widely known by Curology: an online photo consultation leads to a prescription custom formula shipped directly to your door. The "Curology adjacent" label reflects that Agency competes in the same market segment and uses a broadly similar service architecture, not that it is owned by or affiliated with Curology, Inc.

Understanding who actually owns and operates a telehealth brand matters for women in ways it may not for a general consumer. Prescription skincare formulas dispensed through these platforms can contain actives, including tretinoin, azelaic acid, niacinamide, hydroquinone, spironolactone, and various compounded combinations, that carry real pharmacological risk, including documented teratogenicity. Knowing whether the prescribers are licensed, the pharmacy is accredited, and the platform has passed any third-party credentialing review is not a trivial concern.

What the D2C Prescription Model Means for You

In the direct-to-consumer prescription skincare model, you typically:

• Submit photos and a health questionnaire online
• Receive a formula prescribed by a licensed provider (NP, PA, or physician) who reviews your file asynchronously
• Have the formula dispensed by a compounding or retail pharmacy the platform partners with
• Receive the product by mail

This model bypasses the traditional in-person dermatology visit. That convenience is real, but it also means the safeguards that exist in a physical office, such as a provider who can review your full medication list in person, confirm pregnancy status, or catch a drug interaction, are compressed into a digital intake form.

The Curology Connection Explained

Curology launched in 2014 and built significant brand recognition around personalized prescription skincare. Agency is a separate brand that entered the same competitive space. Some coverage has described it as "Curology adjacent" because its service model mirrors Curology's, not because of any corporate relationship. Women searching for one may encounter the other in search results, which is why distinguishing them by their independent credentialing records is worth doing carefully.

LegitScript Status: What It Is and Why It Matters

LegitScript is an independent certification and monitoring service that evaluates online healthcare businesses, including telehealth platforms and online pharmacies, against standards that include compliance with applicable law, responsible prescribing, and transparent business practices. LegitScript certification is recognized by Google, Meta, and other major ad platforms as a condition of running healthcare advertising. It is also used by patients as a trust signal.

A platform can operate legally without LegitScript certification, but certification provides an independently audited confirmation that the service meets defined standards. The absence of certification does not automatically mean a service is problematic. It does mean the burden of verification shifts to you as the patient.

How to Check a Platform's LegitScript Status Yourself

LegitScript maintains a public database. You can search any telehealth or online pharmacy by name at legitscript.com/lookup. At the time this article was reviewed, an independent search for Agency under its current and prior brand names did not return a verified certified listing. Women should run this search themselves before subscribing, because certification status can change.

What Certification Covers

LegitScript evaluates:

• Licensing of prescribers and pharmacies in applicable states
• Requirement for a valid prescription before dispensing
• Transparent pricing and no deceptive billing
• Accessible contact information and complaint processes
• Compliance with FDA and DEA regulations where applicable

A certified telehealth platform has agreed to ongoing monitoring, not just a one-time audit. That ongoing component matters because formularies and ownership can change.

FDA and Compounding Pharmacy Oversight

Many D2C skincare platforms dispense compounded formulas rather than FDA-approved finished drug products. Compounding sits in a distinct regulatory category. The FDA regulates compounding pharmacies under the Federal Food, Drug, and Cosmetic Act, and Section 503A pharmacies (traditional compounders) must comply with state board oversight and may not commercially distribute. Section 503B outsourcing facilities face additional FDA inspections.

This distinction matters for women because:

• A compounded tretinoin formula is not the same regulatory object as FDA-approved tretinoin (Retin-A)
• Compounded products are not FDA-approved for safety, efficacy, or sterility in the same way approved drugs are
• Quality control varies by pharmacy

The FDA has issued warning letters to compounding pharmacies that failed to meet current good manufacturing practice standards. If a D2C platform partners with a non-compliant compounder, the product reaching your skin may not have been manufactured under adequate quality controls.

How to Verify the Dispensing Pharmacy

When you receive a shipment from any prescription skincare platform, the dispensing pharmacy's name and license number should appear on the label. You can verify that pharmacy's license at your state pharmacy board website. The National Association of Boards of Pharmacy (NABP) also maintains a list of "Not Recommended" online pharmacies and a separate VIPPS accreditation program for verified internet pharmacy practice sites.

BBB Standing and Consumer Complaints

The Better Business Bureau (BBB) provides accreditation to businesses that meet its standards for transparency, advertising accuracy, and responsiveness to complaints. BBB accreditation is a relatively low bar compared to healthcare-specific credentialing, but the complaint record offers useful signal about billing practices, cancellation difficulty, and customer service, areas where D2C subscription skincare services have historically generated friction.

A useful framework for evaluating any D2C prescription skincare brand combines four independent checks rather than relying on any single source:

1. LegitScript certification lookup (legitscript.com/lookup)
2. State pharmacy board license verification for the dispensing pharmacy
3. NABP Not Recommended list or VIPPS accreditation check
4. BBB complaint pattern review (bbb.org), specifically the complaint category breakdown

Common complaint categories across D2C skincare platforms include: difficulty canceling subscriptions, charges after cancellation, formula changes without notice, and delayed shipping of time-sensitive prescriptions. Women with hormonally driven skin conditions, including cystic hormonal acne tied to the menstrual cycle or perimenopausal skin changes, may depend on formula consistency in a way that makes unexplained reformulation particularly new.

Women's-Health Framing: Why This Review Is Different for Women

Prescription skincare is not a gender-neutral clinical topic. The conditions these platforms most commonly treat, acne, melasma, post-inflammatory hyperpigmentation, and rosacea, are significantly shaped by female sex hormones, the menstrual cycle, and reproductive life stage.

Hormonal Acne Across the Life Span

Acne affects approximately 50% of women in their 20s and up to 25% of women in their 40s, with a well-documented pattern of perimenstrual flaring driven by progesterone and androgen fluctuation. Women in perimenopause experience a second wave of acne as estrogen declines and relative androgen activity rises. A D2C platform that prescribes topical tretinoin or azelaic acid without asking about cycle timing, hormonal contraception, or menopausal status is missing clinical context that affects both formula choice and realistic outcome expectations.

Melasma and Hormonal Triggers

Melasma is strikingly more common in women than men. Up to 90% of melasma cases occur in women, and the condition is closely tied to estrogen exposure, whether from pregnancy (chloasma), combined oral contraceptives, or hormonal IUDs. A prescription that includes hydroquinone addresses the pigment but does not address the hormonal driver. A clinically thorough intake would ask about your contraceptive method and any plans to become pregnant, because continuing a hormonal trigger while treating the symptom produces limited results.

Perimenopause and Skin Changes

Skin collagen declines by approximately 30% in the first five years after menopause, and barrier function decreases with falling estrogen. Tretinoin remains one of the most evidence-supported topical agents for photoaging, but perimenopausal skin is often more sensitive and may require lower starting concentrations (0.025% rather than 0.05% or 0.1%) and longer titration schedules than the standard adult approach. A photo-based intake form may not capture this nuance.

Pregnancy, Lactation, and Contraception: Critical Safety Section

If you are pregnant, trying to conceive, or breastfeeding, this section applies directly to you.

Several actives commonly prescribed by D2C skincare platforms carry serious reproductive safety concerns.

Tretinoin

Tretinoin is a retinoid. All retinoids are known teratogens. Systemic retinoids such as isotretinoin carry FDA Pregnancy Category X designation and require the iPLEDGE program, but topical tretinoin (Retin-A) is classified as Pregnancy Category C (under the older system) or "avoid use" under current labeling. ACOG recommends avoiding topical tretinoin during pregnancy due to theoretical teratogenic risk based on animal data and isolated case reports. Women trying to conceive should discontinue tretinoin before attempting pregnancy.

During lactation, topical tretinoin has minimal systemic absorption, and limited data suggest negligible transfer into breast milk. However, most clinicians recommend avoiding use on chest or breast areas and consulting a provider before continuing during breastfeeding.

Hydroquinone

Hydroquinone is FDA-approved at 2% over-the-counter concentration and prescribed at 4% and higher. The FDA proposed in 2020 to reclassify hydroquinone from Category I (generally recognized as safe and effective) due to insufficient safety data. Systemic absorption through skin does occur. Pregnancy safety data in humans are limited. Most dermatologists and OB-GYNs advise discontinuing hydroquinone during pregnancy and breastfeeding as a precaution.

Azelaic Acid

Azelaic acid (15-20% prescription formulations) has a more reassuring pregnancy safety profile. It is classified as Pregnancy Category B under the old system, meaning animal studies showed no risk and adequate human studies are lacking but the drug is considered relatively low risk. It is one of the preferred topical treatments for acne and melasma during pregnancy when a prescription active is clinically indicated.

Spironolactone (Oral, When Prescribed Alongside Topical)

Some platforms also prescribe oral spironolactone for hormonal acne. Spironolactone is an anti-androgen. It is absolutely contraindicated in pregnancy due to risk of feminization of a male fetus and other fetal harm. ACOG Committee Opinion supports its use for acne in reproductive-age women only with reliable contraception. Any platform prescribing spironolactone without documenting contraception use is not following standard of care.

What a Responsible Platform Should Ask

A telehealth platform prescribing these actives should, at minimum, ask:

• Are you pregnant, trying to become pregnant, or breastfeeding?
• What contraception are you using, if any?
• Have you had any prior pregnancy complications?

If the intake form you completed did not include these questions, that is a quality signal worth noting.

Who This Service Is Right For, and Who Should Be Cautious

Life Stages Where D2C Prescription Skincare May Be Appropriate

Reproductive years (not pregnant, not actively trying to conceive). Women with hormonally driven acne or early melasma who have reliable contraception in place and are not planning pregnancy in the near term are reasonable candidates for tretinoin or hydroquinone-based D2C formulas, provided the prescribing provider reviews the full clinical picture.

Postpartum (after breastfeeding is complete). Many women experience post-inflammatory hyperpigmentation and hormonal acne flares in the months after delivery. Once breastfeeding is complete, prescription actives become appropriate options again, with the same contraception considerations.

Perimenopause and post-menopause. Tretinoin for photoaging, azelaic acid for rosacea, and topical niacinamide for barrier support are well-suited to this life stage. The main adjustment is starting at lower concentrations to account for thinner, drier, more reactive skin. A platform that does not ask your age or hormonal status cannot make this adjustment.

Life Stages Where Caution Is Essential

Pregnancy. Avoid tretinoin and hydroquinone. Use azelaic acid only after discussing with your OB-GYN or midwife.

Trying to conceive. Discontinue tretinoin before attempting conception. Stop spironolactone and use reliable contraception until the cycle is firmly paused.

Breastfeeding. Avoid hydroquinone. Minimize tretinoin use and avoid applying to chest. Azelaic acid is generally considered acceptable but confirm with your provider.

Perimenopause with significant skin sensitivity. Request lower concentration formulas and longer titration windows than a standard-adult intake form may generate.

What Independent and Clinical Sources Say

Two named guideline documents are directly relevant here.

The American Academy of Dermatology's acne guideline states that evidence supports topical retinoids as first-line therapy for acne vulgaris, with tretinoin, adapalene, and tazarotene all carrying strong evidence ratings. The AAD guideline does not specifically address D2C telehealth delivery models, but its prescribing standards apply regardless of delivery channel.

WomanRx editorial board member Elena Vasquez, MD (OB-GYN), reviewed this article and noted: "The question I want every woman to ask before subscribing to any prescription skincare platform is simple: did my prescriber ask whether I am pregnant, trying to get pregnant, or breastfeeding? If that question was not in the intake form, the platform is not practicing to an adequate standard of care for a reproductive-age woman. Tretinoin is not a trivial prescription."

The Menopause Society (formerly NAMS) position statement on skin changes notes that declining estrogen significantly alters skin structure and barrier function, changes that have direct implications for how topical prescription actives are tolerated and should be dosed in perimenopausal and postmenopausal women.

Evidence Gaps: What We Do Not Know

Clinical trial data on telehealth-dispensed compounded prescription skincare specifically in women is thin. Most efficacy data for tretinoin, hydroquinone, and azelaic acid comes from trials of the individual active ingredients, not of D2C compounded combinations delivered through asynchronous telehealth. Women have historically been under-represented in dermatology trials, and data specific to perimenopausal skin remain particularly sparse.

What this means practically: when a D2C platform claims its formula is "clinically proven," that claim is drawing on ingredient-level evidence, not evidence for the specific formula, the specific delivery model, or your specific hormonal profile. That gap is not a reason to avoid prescription skincare, but it is a reason to understand what evidence actually supports and what is inferred.

Practical Steps Before You Subscribe

Before entering payment information on any prescription skincare platform, including Agency, take these steps:

1. Search the platform by name at legitscript.com/lookup and confirm certification status.
2. Identify the dispensing pharmacy from the platform's FAQ or terms of service. Look that pharmacy up at your state board website and check the NABP Not Recommended list.
3. Read the intake form before completing it. If it does not ask about pregnancy, breastfeeding, or contraception, that is a red flag.
4. Check bbb.org for the complaint pattern. Billing and cancellation complaints are the most common category for subscription skincare platforms and can affect whether you can stop a prescription you no longer want.
5. If you are pregnant, trying to conceive, or breastfeeding, consult your OB-GYN or midwife before starting any prescription topical.

The FDA's BeSafeRx program provides guidance on how to safely use online pharmacies and prescription services, including a checklist for evaluating whether a site is operating legally.